<DOC>
	<DOCNO>NCT00712556</DOCNO>
	<brief_summary>RATIONALE : Diagnostic procedure , fluorine 18-fludeoxyglucose positron emission tomography ( PET ) scan , may help doctor predict patient 's response treatment help plan best treatment . PURPOSE : This phase I trial study fluorine 18-fludeoxyglucose PET scan see well predict outcomes patient undergone high-dose chemotherapy autologous stem cell transplant non-Hodgkin lymphoma .</brief_summary>
	<brief_title>PET Study Patients With Non-Hodgkin Lymphoma</brief_title>
	<detailed_description>OBJECTIVES : - To determine fluorine 18-fludeoxyglucose positron emission tomography scan , perform early day 30 high-dose chemotherapy autologous stem cell transplantation , may useful identify patient non-Hodgkin lymphoma may benefit early intervention , include reduce intensity stem cell transplantation additional therapy , preempt disease relapse improve overall survival . OUTLINE : Conventional imaging , biopsy , clinical examination finding review determine patient clinical outcome ( e.g. , complete remission , disease progression/relapse , death related primary disease ) .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Fluorides</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis nonHodgkin lymphoma Has undergone highdose chemotherapy follow autologous stem cell transplantation Vanderbilt University March 1997 August 2005 Has undergone fluorine 18fludeoxyglucose PET within 70 day prior and/or approximately 30 day 100 day highdose chemotherapy autologous stem cell transplantation PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>stage III adult Burkitt lymphoma</keyword>
	<keyword>stage III adult diffuse large cell lymphoma</keyword>
	<keyword>stage III adult diffuse mixed cell lymphoma</keyword>
	<keyword>stage III adult diffuse small cleave cell lymphoma</keyword>
	<keyword>stage III adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage III adult lymphoblastic lymphoma</keyword>
	<keyword>stage III grade 1 follicular lymphoma</keyword>
	<keyword>stage III grade 2 follicular lymphoma</keyword>
	<keyword>stage III grade 3 follicular lymphoma</keyword>
	<keyword>stage III mantle cell lymphoma</keyword>
	<keyword>stage III marginal zone lymphoma</keyword>
	<keyword>stage III small lymphocytic lymphoma</keyword>
	<keyword>stage IV adult Burkitt lymphoma</keyword>
	<keyword>stage IV adult diffuse large cell lymphoma</keyword>
	<keyword>stage IV adult diffuse mixed cell lymphoma</keyword>
	<keyword>stage IV adult diffuse small cleave cell lymphoma</keyword>
	<keyword>stage IV adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage IV adult lymphoblastic lymphoma</keyword>
	<keyword>stage IV grade 1 follicular lymphoma</keyword>
	<keyword>stage IV grade 2 follicular lymphoma</keyword>
	<keyword>stage IV grade 3 follicular lymphoma</keyword>
	<keyword>stage IV mantle cell lymphoma</keyword>
	<keyword>stage IV marginal zone lymphoma</keyword>
	<keyword>stage IV small lymphocytic lymphoma</keyword>
	<keyword>recurrent adult Burkitt lymphoma</keyword>
	<keyword>recurrent adult diffuse large cell lymphoma</keyword>
	<keyword>recurrent adult diffuse mixed cell lymphoma</keyword>
	<keyword>recurrent adult diffuse small cleave cell lymphoma</keyword>
	<keyword>recurrent adult immunoblastic large cell lymphoma</keyword>
	<keyword>recurrent adult lymphoblastic lymphoma</keyword>
	<keyword>recurrent childhood large cell lymphoma</keyword>
	<keyword>recurrent childhood lymphoblastic lymphoma</keyword>
	<keyword>recurrent childhood small noncleaved cell lymphoma</keyword>
	<keyword>recurrent cutaneous T-cell non-Hodgkin lymphoma</keyword>
	<keyword>recurrent grade 1 follicular lymphoma</keyword>
	<keyword>recurrent grade 2 follicular lymphoma</keyword>
	<keyword>recurrent grade 3 follicular lymphoma</keyword>
	<keyword>recurrent mantle cell lymphoma</keyword>
	<keyword>recurrent marginal zone lymphoma</keyword>
	<keyword>recurrent small lymphocytic lymphoma</keyword>
	<keyword>recurrent mycosis fungoides/Sezary syndrome</keyword>
	<keyword>nodal marginal zone B-cell lymphoma</keyword>
	<keyword>splenic marginal zone lymphoma</keyword>
	<keyword>NC stage II adult immunoblastic large cell lymphoma</keyword>
	<keyword>NC stage II adult lymphoblastic lymphoma</keyword>
	<keyword>NC stage II grade 1 follicular lymphoma</keyword>
	<keyword>NC stage II grade 2 follicular lymphoma</keyword>
	<keyword>NC stage II grade 3 follicular lymphoma</keyword>
	<keyword>NC stage II mantle cell lymphoma</keyword>
	<keyword>NC stage II marginal zone lymphoma</keyword>
	<keyword>NC stage II small lymphocytic lymphoma</keyword>
</DOC>